5Ilkova H, Glaster B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type of 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20 : 1253- 1356.
6Garber A J, Wahlen J, Wahl T, et al. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab, 2006, 8:58-66.
7Hirsch IB. Insulin Analogues. N Engl J Med, 2005,352:174-183.
8Rosenstoek J, Schwartz SL, Clark CM, et al. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine ( HOE 901 ) and NPH insulin. Diabetes Care, 2001,24:631-636.
9Heinemann L, Linkeschova R, Rave K. Time-action profile of the longacting insulin analog insulin glargine ( HOE901 ) in comparison with those of NPH insulin and placebo. Diabetes Care, 2000,23:644-649.
10Boehm BO, Vaz JA, Biondsted L, et al. Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes. Eur J Int Med, 2004, :496-502.
